Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc + Atazanavir/Ritonavir in Naïve R5 HIV-1
NCT00827112Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Mar 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Mar 2009; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00827112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827112.